Biotech firms lobby states to limit generic competition in USA

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.671, 2013-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Consumer Perceptions of Generic Drug Substitution Practices in the USA

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 4, 2004-12 ,pp. : 262-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Effect of Generic Competition on Prescription to Over-the-Counter Switching

By Hollenbeak C.S.  

PharmacoEconomics, Vol. 16, Iss. 6, 1999-12 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite

Amphotericin B Formulations – The Possibility of Generic Competition

By  

Pharmaceutical Nanotechnology, Vol. 1, Iss. 4, 2013-11 ,pp. : 250-258

Bentham Science Publishers

Access to resources Recommend Favorite

US wards off generic competition, while Japan considers embracing it

By  

Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review

By Puig-Junoy Jaume  

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 649-663

Adis International

Access to resources Recommend Favorite